Coronado, California, U.S., October 20, 2026
Spine Innovation, LLC has announced the successful completion of the first surgical procedure using its LOGIC™ Titanium Expandable Interbody System, a medical device designed for transforaminal lumbar interbody fusion (TLIF). The procedure was performed on October 14, 2026, by orthopedic spine surgeon Robert Eastlack, MD, at Scripps Green Hospital in La Jolla, California. The milestone represents an important step in the company’s efforts to advance spinal implant technology for patients requiring lumbar fusion surgery. The LOGIC Titanium Implant System is engineered to provide a smaller insertion profile that expands within the disc space to create a larger footprint intended to support spinal stability and bone fusion. By combining an expandable implant design with a porous titanium lattice structure, the system aims to address key challenges in spinal reconstruction, including disc-height restoration, spinal alignment and implant stability.
LOGIC Titanium System Advances Lumbar Fusion Surgery
The LOGIC Titanium Expandable Interbody System is designed for transforaminal lumbar fusion procedures, which are performed to stabilize affected spinal segments and encourage fusion between adjacent vertebrae. These procedures may be recommended for selected patients with degenerative disc disease and other conditions affecting the lumbar spine when nonsurgical treatments have not provided adequate relief. During spinal fusion, an interbody implant is placed between vertebrae after the affected disc is removed. The implant helps maintain the space between the vertebrae and provides a structure that supports bone growth across the treated segment. Implant positioning, stability and the available surface area for fusion are important considerations in surgical planning. The LOGIC Ti implant is designed to enter the disc space through a relatively small insertion profile before expanding to an 18 × 26 mm footprint. According to Spine Innovation, the expanded design is intended to span the vertebral body and help restore disc height and sagittal balance while resisting subsidence, which occurs when an implant sinks into adjacent vertebral bone, and expulsion, in which an implant moves out of its intended position. These design characteristics aim to support surgeons performing lumbar fusion while providing a larger implant footprint after placement. However, the first completed procedure represents an initial clinical-use milestone and does not, by itself, establish superior patient outcomes compared with other available spinal implants.
Porous Titanium Material Supports Bone Fusion
A key component of the system is OsteoSync™ Ti, a commercially pure titanium lattice material developed by Sites Medical. The porous structure is intended to support bone integration by providing a surface conducive to bone growth around the implant. According to the company announcement, OsteoSync Ti has been implanted in more than 350,000 orthopedic and spine patients since 2014. This reported experience provides a background for the material used in the LOGIC Ti system, although experience with a material across different devices does not independently establish the clinical performance of this specific implant design. The LOGIC implant design was previously used in the United States in a version manufactured from polyether ether ketone (PEEK). The titanium version incorporates a different implant material while retaining the expandable design concept. Titanium-based porous structures are used in orthopedic implants because their surface characteristics can support bone integration, an important consideration in procedures intended to achieve lasting spinal fusion. The system’s performance will depend on factors such as patient selection, surgical technique, bone quality, implant positioning and postoperative care. Longer-term clinical follow-up will be needed to evaluate fusion rates, implant stability, complications and patient-reported outcomes.
Advertisement
Spine Innovation Seeks to Expand Clinical Adoption
Founded in 2013 in collaboration with surgeon inventors from Scripps Health, Spine Innovation develops technologies intended to address unmet needs in spinal surgery. The first procedure using the LOGIC Ti system marks progress in bringing the titanium version into clinical use. The company has stated that it is seeking U.S. sales and distribution partners to expand the implant system’s clinical reach. Partnerships could help support broader availability, subject to applicable regulatory requirements, commercial arrangements and adoption by healthcare providers. The Titanium Interbody System received FDA 510(k) clearance, supporting its marketing in the United States for specified spinal fusion indications. This regulatory status should be distinguished from evidence of clinical superiority: clearance does not establish that the system produces better outcomes than competing devices. For spine surgeons and medical technology professionals, the LOGIC Ti system illustrates continued innovation in expandable interbody implants and porous titanium materials. Future clinical experience will help clarify how the system performs in routine surgical practice and whether its design offers meaningful advantages for eligible patients undergoing lumbar fusion. The first LOGIC Ti surgery marks a development milestone for Spine Innovation, with further clinical experience needed to establish the implant’s long-term safety, effectiveness and role in spinal fusion procedures.
Source: Spine Innovation press release
